The Act is organised around a small set of recurrent legal objects: licence, registration, registered pharmacist, pharmacy business, pharmacy department, pharmacy depot, and proprietary interest. Each term triggers different rights and duties under the scheme.

Key definitions and consequences:

• “Pharmacy” and “pharmacy business”: “pharmacy” means premises where a registered pharmacist supplies, compounds or dispenses medicines to the public; “pharmacy business” means the business carried on at a pharmacy (s 3). Those terms determine the licensing threshold: a person must hold a licence and have the premises registered before carrying on a pharmacy business (s 21).
• “Pharmacy department”: the part of premises of certain funded agencies, community health centres or hospitals set aside for supplying medicines to patients and staff; departments require registration and a licence to operate (s 3; s 22).
• “Pharmacy depot”: premises where prescriptions or dispensed medicines may be left and collected; depots must be registered and have an operator responsible for operation and security (s 3; ss 23, 48).
• “Registered pharmacist”: a person registered under the Health Practitioner Regulation National Law to practise in the pharmacy profession (s 3). Many procedural and operational duties are tied to a registered pharmacist being present or in charge (e.g. ss 29-31, Schedule items 5-8).
• “Licence” and “registration”: a licence authorises an eligible person to carry on a pharmacy business or department (Part 3 Div 1); registration is of premises where pharmacy services will be provided (Part 3 Div 2). Both are required before operating (s 21).
• “Proprietary interest” and ownership controls: the Act limits who may own or have a proprietary interest in a pharmacy business (s 5). Ownership is mainly limited to registered pharmacists, to companies whose directors and shareholders are registered pharmacists (s 5(1)(a)-(b)), certain mutual companies with specific features (s 5(1)(c)-(e)), or a person authorised by the Authority to meet access needs (s 5(1)(f)). Registered pharmacists and pharmacist companies are limited to ownership of five separate pharmacy businesses (s 5(2)). Division 2 (ss 12-19) contains more elaborate caps and transition exceptions for mutual‑type companies formed and amalgamated before specific dates; it also prescribes how to count subsidiaries and round figures (ss 18-19).
• “Authority standard”: the Authority may issue standards which regulate operation, but only after consulting affected licensees and obtaining Ministerial approval (s 86). Standards take effect on publication in the Government Gazette (s 86(5)) and the Authority must publish them on its website (s 86(6)). Section 86(7) permits bypassing consultation where an immediate public health or safety need exists.

Regulation of business activity and contractual constraints:

• The Act voids contractual provisions that give third parties control rights over the way the pharmacy business is carried on or variable profit‑linked payments to a non‑licensee (s 11). That provision alters the contractual bargaining space for finance and security arrangements.

Regulatory instruments and administration:

• The Authority sets fees (s 104) to recover its administration costs (s 104(2)) and manages a fund (ss 102-103). It may delegate many powers to staff, but not the core powers to refuse or revoke licences or registrations, nor the power to delegate (s 98). The membership and governance of the Authority are prescribed (ss 87-96), including composition requirements (three registered pharmacists, one Australian lawyer and one non‑pharmacist (s 87)) and limited immunity for members acting in good faith (s 97).

Enforcement and review:

• A mix of administrative sanctions (conditions, cautions, revocation; ss 40, 59-61) and criminal penalties (monetary penalties for offences) is used. Investigative powers include document examination, entry to premises (physically or by audio visual link, s 68(1A)), seizure and retention of documents and seeking search warrants (ss 67-76). Affected persons may seek review by VCAT of specified decisions (s 62).

The Act’s central policy lever is therefore a mixture of ownership controls, perimeter licencing and registration gates, operational prescriptive requirements (supervision, records, security) and a regulator empowered to set standards, inspect, and sanction.

Primary regulated subjects:

• Registered pharmacists: the Act predicates many operational duties on registered pharmacists (s 3 definition). Registered pharmacists may themselves be licensees (s 5(1)(a)), may head or personally supervise pharmacies (ss 30, Schedule items 5-8), and must notify the Authority of where they practise (s 28). The Act excludes provisionally registered pharmacists from the “registered pharmacist” category for ownership purposes (s 5(5)).
• Licensees: persons (individuals, companies or approved entities) who hold licences to carry on pharmacy businesses or departments. Licence holders have duties to ensure premises are registered, to comply with licence conditions, to authorise only permitted activities on registered premises (s 24) and to notify the Authority of various changes including cessation of business (s 25), company changes (s 27), and establishment intentions (s 20).
• Companies and corporate structures: companies whose directors and shares are held by registered pharmacists are an express, permissible ownership form (s 5(1)(b)). A different permitted class is companies with friendly society-type, mutual structures satisfying the detailed criteria in s 5(1)(c)-(e), including size and constitution requirements and satisfying the Authority as to not being profit‑dominant (s 5(4)). The Corporations Act will shape how these entities are formed, amalgamated and how shareholdings and directors are altered; the Act requires notice to the Authority for certain ASIC filings (s 7) and gives the Authority power to require information (s 8).
• Operators of pharmacy depots: the Act defines an operator and imposes duties relating to secure storage and confidentiality of medicines and records kept at depots (s 3; s 33; s 48).
• Employers and staff at pharmacies: any person who supplies, compounds or dispenses medicines must be under the supervision of a registered pharmacist (s 29(2)), and the licensee or pharmacist in charge may be criminally liable for knowingly allowing services to be provided unsupervised (s 30(2)).
• Registered funded agencies, community health centres and hospitals: where they seek to establish pharmacy departments they must be registered under this Act and, in the case of registered funded agencies, the Authority must consult the Secretary before granting a licence (s 38(3); s 22).
• The Authority itself and its staff: the Authority and the registrar are tasked with licensing, registration, inspection and enforcement (ss 82-99). The Act authorises the registrar and staff to commence proceedings in the name of the Authority (s 64) and confers identification and entry powers on authorised persons (ss 65-66, 68).
• Other agencies: the Act contemplates disclosure of information to the Pharmacy Board of Australia, to the Secretary in relation to administration of certain health Acts including the Voluntary Assisted Dying Act 2017 (s 107), and to corresponding bodies in other jurisdictions (s 107(1)(d)).

Indirectly affected groups and markets:

• Lenders, landlords and financiers: s 11 voids certain contract terms in security documents that would give non‑licensees control over the direction of the pharmacy business, limit access to accounts, or make payments variable by reference to profits, which impacts how security and commercial terms can be structured and enforced.
• Consumers and patients: the Act’s supervision, recordkeeping, hygiene and security requirements (ss 29-33; Schedule) regulate the safety and availability of pharmacy services; the Authority’s power to revoke licences or registrations where there are serious risks to public health or safety (ss 55-56) has direct consumer safety implications.
• Competitors and investors in retail health markets: the ownership caps (s 5(2) and Div 2 ss 12-19) influence market structure by limiting consolidation by registered pharmacists and specified companies, and by creating permitted exceptions and historical transition thresholds that affect acquisition strategies.

Who decides and who pays:

• The Authority decides licensing, registration, conditions, standards and sanctions (ss 36-41, 44-50, 86, 59-61). The Authority sets fees and is entitled to ensure fees cover the cost of administering the Act (ss 104(1), 104(2)). Those fees and fines are paid into the Victorian Pharmacy Authority Fund and finance the Authority’s operations (ss 102-104). The Minister is a consultation partner and approves standards (ss 84, 86(3)) and may direct certain disclosures to the Minister (s 106).

Duties imposed by the Act (owner/operator/licensee/registered pharmacist)

Ownership and structural duties

• Ownership restrictions: a person must not own or have a proprietary interest in a pharmacy business unless they fall within the permitted classes in s 5(1) (registered pharmacist, pharmacist company, specific mutual companies, or Authority‑approved person). Registered pharmacists and companies described in s 5(1)(b) are limited to ownership of no more than five separate pharmacy businesses (s 5(2)). The Act treats each separate premises as a separate pharmacy business (s 10).
• Notice and information duties: companies with mutual structure changes must notify the Authority within 30 days of lodging specified ASIC notices (s 7). The Authority may require any person referred to in s 5(1) to produce information and documents relating to ownership or proprietary interest (s 8). It is an offence to fail, refuse or wilfully mislead the Authority when complying with ss 7 or 8 (s 9).

Operational duties

• Licence and registration prerequisites: a person must not establish or carry on a pharmacy business unless the ownership requirements are satisfied and the Authority has registered the premises and granted a licence (s 21). Pharmacy departments and depots also require registration and licence/eligibility as specified (ss 22-23).
• Controls on business activity: licensees must not authorise other business or activities in registered premises unless the activity is permitted by the licence or approved by the Authority (s 24).
• Notifications about business changes: licensees must give the Authority at least 14 days’ notice before ceasing to carry on a pharmacy business (s 25), and must give similar advance notices where pharmacy departments cease operation (s 26) or when company licensees change their shareholding, directorship or office bearers (s 27). Registered pharmacists must notify the Authority of the address of the pharmacy or pharmacy department within 14 days of commencing work there (s 28), subject to agreed alternative arrangements (s 28(2)).
• Supervision and access: pharmacies and pharmacy departments must be personally supervised by a registered pharmacist while open for business (s 30(1)). The Act criminalises knowingly allowing a pharmacy service to be provided unsupervised by a registered pharmacist (s 30(2)). Access to closed premises is restricted absent a registered pharmacist (s 31).
• Supply and dispensing obligations: registered pharmacists must supply, compound or dispense medicines only from registered premises (s 29(1)), except in special circumstances approved by the Authority. Those providing pharmacy services must be under the supervision of a registered pharmacist (s 29(2)).
• Recordkeeping and certification: registered pharmacists must keep a record of every prescription supplied, containing specified fields, in English, and retain records securely for at least three years; records must be made at time of dispensing and certified within 24 hours by handwritten signature (s 32(2)-(4); Schedule items 10-11).
• Security for depots: the operator of a pharmacy depot must keep medicines and records secure (s 33; s 48 prescribes secure storage, confidentiality and privacy arrangements).
• Avoiding undue influence: a clause in security documents that gives non‑licensees control over the operation, access to books except for compliance checking, or profit‑linked payments is void (s 11).

Regulatory rights and procedural protections

• Application and decision rights: eligible persons may apply for licences and registrations (ss 36, 44); the Authority must give written notice of decisions and reasons where an application is refused (ss 41, 50).
• Conditions and variation: the Authority may impose conditions on licences or registrations at grant, during the licence period (with notice and grounds 28 days prior where imposed without consent) or on renewal (s 40; s 49).
• Investigation and response rights: the Authority may investigate and convene panels to hear matters (ss 53-58). Panel hearings are conducted “with as little formality and technicality as permitted” and are not public (s 58(1)(a), (f)), the panel is bound by rules of natural justice (s 58(1)(e)), and the licensee may be present and make submissions and be accompanied by another person who may be a lawyer (s 58(1)(c)-(d); note s 58(1)(b) which states there is no right to legal representation at the panel hearing).
• Sanctions and remedies: panels may impose conditions, revoke licences/registrations, caution or reprimand, or allow licence/registration to continue (s 59). The Authority can also revoke a licence without referral to a panel, providing written notice that sets out the revocation or an opportunity to remedy (s 60). Where immediate revocation is required to reduce a serious risk to public health or safety, the Authority may revoke without notice (s 60(4)).
• Review rights: affected persons may apply to VCAT for review of specified Authority decisions (refusal to grant licence/registration, imposition of conditions, revocation) within 28 days of receiving notice and reasons (s 62(1)-(2)). The Authority must publish determinations of VCAT on its website and notify persons previously notified of the original decision (s 62(3)-(4)).
• Protection against self‑incrimination: natural persons may refuse to give information that would tend to incriminate them, but production of documents is not a reasonable excuse (s 78(1)-(3)). If a person claims production would incriminate, that document is not admissible against them in criminal proceedings (s 78(3)).

Administrative powers supporting duties and rights

• Standards issuance: the Authority may issue standards after consulting affected licensees and with Ministerial approval (s 86). Standards bind practice to the extent they are consistent with the Act and regulations; where inconsistencies exist, the Act or regulations prevail (s 86(8)).
• Fee and fund management: the Authority fixes fees for licences, registrations and late lodgement (ss 36(2)(d), 43A, 52A; s 104). The Authority must use the Fund to pay operating expenses and, in each year, an amount to meet VCAT expenses for functions under this Act (ss 102-105).

The Act combines administrative sanctions (conditions, revocation, reprimand) with criminal offences carrying pecuniary penalties and gives investigatory powers to authorised persons and to the Authority. Enforcement is primarily administered by the Authority and its authorised agents (ss 64-66; Part 4).

Monetary penalties and specified offences

• Ownership breach: s 5 contains express offence penalties where a person owns or has a proprietary interest in a pharmacy business in contravention of s 5(1). The penalty is 240 penalty units for a natural person and 1200 penalty units for a body corporate (s 5 notes).
• Failure to comply with information and notice requirements: failing to comply with ss 7 or 8 (notice to Authority about company changes or producing information/documents on request) or wilfully misleading the Authority is an offence (s 9) with penalties of 60 penalty units for a natural person and 300 units for a body corporate.
• Establishment and operation offences: operating a pharmacy business without satisfying s 21 (licence and registration) carries penalties , 240 penalty units for a natural person and 1200 for a body corporate (s 21). Establishing or carrying on a pharmacy depot without registration is an offence with a 60‑unit penalty (s 23). Authorising unauthorised business in registered premises attracts a 60‑unit penalty (s 24).
• Notification defaults: failing to notify the Authority of cessation of business (s 25), change in company details (s 27) or failing to notify commencement address by registered pharmacists (s 28) carry lower penalties (10 penalty units).
• Supervision and access: knowingly or negligently allowing pharmacy services to be provided unsupervised by a registered pharmacist is an offence with penalty not exceeding 60 penalty units (s 30(2)). Allowing access to closed premises without a registered pharmacist is 60 units (s 31).
• Use of title: intentionally or recklessly using “pharmacy”, “pharmacy practice” or “pharmacy business” except in relation to a licensed pharmacy is an offence , 60 penalty units for a natural person and 300 units for a body corporate (s 34).
• Enforcement obstruction and false information: refusing or failing to comply with requirements of authorised persons (s 77) is an offence with penalty 60 units; giving false or misleading information to an authorised person (s 79) is 60 units; hindering or obstructing an authorised person exercising a power under Part 4 (s 80) is 60 units.

Investigatory and coercive powers

• Document examination: the Authority may require pharmacists or licensees to submit documents kept in connection with the pharmacy business for examination, and may direct certified copies be made or retain documents as part of hearings (s 67). Before requiring submission, the Authority must warn of the offence for non‑compliance and inform natural persons of s 78 (s 67(2)).
• Entry and inspection: authorised persons may enter premises of any pharmacy business, department or depot to inspect stocks, equipment, prescriptions and documents and to copy or extract documents (s 68(1)-(1A)). Entry is limited to times when the business is open for business or providing pharmacy services (s 68(2)). Authorised persons must produce identity cards prior to exercising powers (s 66(1)-(2)).
• Search warrants and seizure: the Authority may apply to a magistrate for search warrants where there are reasonable grounds to suspect a contravention (s 70(1)). A warrant must specify the suspected offence or grounds of revocation, premises, things to be searched for and a cessation day not later than seven days after issue (s 70(4)). The Magistrates’ Court Act 1989 rules apply to warrants (s 70(3)).
• Handling of seized material: authorised persons must give copies or receipts for seized items on request (s 73). Copies of seized documents must be provided within 21 days and are admissible as evidence equal to the original (s 74). Documents seized should be returned where the reason for seizure no longer exists, and there are statutory time limits on retention (s 75). The Magistrates’ Court may extend retention beyond three months up to a 12‑month total where necessary and in the interests of justice (s 76).
• Protection against self‑incrimination: natural persons may refuse to give information that would tend to incriminate them (s 78(1)), but production of a document is not a reasonable excuse (s 78(2)), and if a claim is made before production, the produced document is not admissible against them in criminal proceedings (s 78(3)).

Administrative sanctions and process

• Revocation and conditions: the Authority may revoke licences or registrations on specified grounds (ss 55-56), or impose conditions on licences or registrations at grant, during the licence period (with notice and grounds if imposed without consent) or on renewal (ss 40, 49). The Authority may convene a panel to hear matters arising from investigations (s 57); panels can impose conditions, revoke licences/registrations or reprimand, with their decisions constituting the Authority’s decision (s 59).
• Urgent revocation: the Authority may revoke without notice where immediate revocation is necessary to reduce or prevent a serious risk to public health and safety (s 60(4)).
• Other enforcement paths: the registrar or an authorised person employed under s 99 may take proceedings in the name of the Authority (s 64), and the Act authorises authorised persons and staff to exercise powers under Part 4 (s 65).

Funding enforcement

• Fees and fund: the Authority may fix fees (including late lodgement fees) and must ensure fee income is sufficient to cover the cost of administration (s 104(1)-(2)). All fees, fines and penalties paid or recovered under the Act must be paid into the Victorian Pharmacy Authority Fund (s 102(2)); the Fund finances enforcement and administration costs (s 102(4)).

The Act embeds cross‑references to national and state law and creates points of regulatory contact. The statutory text itself makes these interactions explicit.

Corporations Act and company law

• Ownership and company structure: the permissibility of companies owning pharmacies is framed in corporate terms: s 5(1)(b) and (c) refer to companies registered under the Corporations Act and to particular company forms (e.g. companies limited by guarantee or shares). Compliance with the Corporations Act (and ASIC filings) triggers notice obligations to the Authority , for example s 7 requires notice to the Authority within 30 days after a notice is lodged with or an application made to ASIC under Part 5 of Schedule 4 to the Corporations Act about specified companies. Counting of subsidiary‑owned pharmacy businesses for the caps is governed by the date of acquisition or incorporation and the treatment of wholly owned subsidiaries (s 18).

Health Practitioner Regulation National Law and practitioner registration

• Definition and interaction: “registered pharmacist” is defined by reference to registration under the Health Practitioner Regulation National Law (s 3). Section 35 explicitly modifies an aspect of the National Law by stating it is not an offence under that law for a person to use the name or title “pharmacist” in respect of a pharmacy business where the person is licensed and services are provided by or under supervision of a registered pharmacist (s 35(1)). Section 35(2) also clarifies that a registered pharmacist who carries on a pharmacy business but does not personally provide pharmacy services is not to be treated, for the purposes of the National Law, as practising as a pharmacist in respect of that business.

Health Services Act 1988 and hospital/community health regulation

• Pharmacy departments: the Act’s definition of “pharmacy department” depends on the Health Services Act 1988 (s 3). The Authority must consult with the Secretary before registering premises for pharmacy departments in registered funded agencies (s 45(2)) and must consult before granting a licence to a registered funded agency to carry on a pharmacy department (s 38(3)). The Act thus interfaces with hospital and community health governance.

Voluntary Assisted Dying Act 2017; Drugs, Poisons and Controlled Substances Act 1981

• Prescription scope and information sharing: the Act’s definitions incorporate a voluntary assisted dying permit within the meaning of the Voluntary Assisted Dying Act 2017 into the definition of “prescription” (s 3). Section 107 authorises disclosure of information to the Secretary in relation to administration of the Drugs, Poisons and Controlled Substances Act 1981 and, as amended, to administration of the Voluntary Assisted Dying Act 2017 (s 107(1)(c)(iii)). Note that some references to s 107(1)(c)(ii) were amended and later repealed as recorded in the Endnotes.

Magistrates’ Court Act 1989 and search warrants

• Warrant form and rules: section 70(3) requires search warrants under the Act to be issued in accordance with the Magistrates’ Court Act 1989 and in a form prescribed under that Act. Section 70(5) states the rules respecting warrants in the Magistrates’ Court Act extend to warrants under s 70. The Magistrates’ Court also has a role in extending retention periods for seized items (s 76).

Interpretation of Legislation Act 1984

• Transitional treatment of re‑enacted provisions: Part 7 includes a specific reminder that nothing in the transitional Part limits operation of the Interpretation of Legislation Act 1984 (s 110) and that several provisions re‑enact with modifications sections of the Health Professions Registration Act; the ILA may affect the interpretation of re‑enacted provisions (s 110).

VCAT and administrative review

• Review channel: decisions of the Authority specified in s 62 (refusal to grant licences or registrations, imposition of conditions, revocation) are subject to review by VCAT, with time limits set at 28 days from receipt of notice and reasons (s 62(1)-(2)). The Authority must publish VCAT determinations and notify affected parties of outcomes (s 62(3)-(4)), creating a record and feedback loop between tribunal outcomes and administrative practice.

Other bodies and information exchange

• Information sharing: the Authority may disclose information collected under the Act to the Pharmacy Board of Australia and committees thereof, relevant Secretaries for certain Acts, and to corresponding bodies in other jurisdictions (s 107). Disclosure is limited to purposes tied to the Authority’s functions, assisting those bodies to perform their functions, or where information is relevant to pharmacist registration under the National Law (s 107(2)).

Regulatory instruments and subordinate law

• Regulations: the Governor in Council may make regulations for matters under the Act including licences, registrations and other necessary matters (s 108). Regulations may adopt external documents, codes or standards and may leave matters for approval or satisfaction of a specified person (s 108(2)(c)-(d)). Standards issued by the Authority must be approved by the Minister and published; where inconsistent, the Act prevails (s 86(3), (4), (8)).

Overall interaction mechanics

• Operationally, the Act sits as a sectoral regulation that overlays company law, the national registration regime for health practitioners, hospital and community health law, and procedural criminal‑law instruments (search warrants, seizure). It creates both information flows (notices to ASIC and the Authority; disclosure to other agencies) and practical constraints (ownership caps, security and supervision requirements) that must be reconciled with corporate governance obligations and health practitioner registration responsibilities.

The statutory text incorporates a sequence of amending Acts and specific textual edits, recorded in the Endnotes’ Table of Amendments. The source document supplies the following discrete amendment milestones that materially changed provisions in the Act as at the version dated 30 March 2022:

• Statute Law Revision Act 2011 (No. 29/2011): commencement detail recorded (Endnotes, Table of Amendments). This Act effected style or minor changes noted at s 3 (Sch. 1 item 68).
• Legal Profession Uniform Law Application Act 2014 (No. 17/2014): s 160(Sch. 2 item 70) commenced on 1 July 2015, and is recorded as having repealed the definition of “Australian lawyer” in s 3(1) (Endnotes Table).
• Access to Medicinal Cannabis Act 2016 (No. 20/2016): inserted definitions and made amendments commencing 14 September 2016; the endnotes show s 149 and s 150 inserted definitions in s 3 and amendments to s 107 respectively (Endnotes).
• Voluntary Assisted Dying Act 2017 (No. 61/2017): amendments (ss 141, 142) commenced on 19 June 2019, affecting the definition of “prescription” to include voluntary assisted dying permits and related disclosure provisions (Endnotes).
• Oaths and Affirmations Act 2018 (No. 6/2018): amended s 68 by insertion (Sch. 2 item 95) to accommodate changes regarding warrants and affirmations; commencement noted as 1 March 2019 (Endnotes).
• Health Legislation Amendment and Repeal Act 2019 (No. 34/2019): inserted or repealed certain definitions; ss 51 and 52 of that amending Act commenced 23 October 2019 (Endnotes).
• Regulatory Legislation Amendment (Reform) Act 2022 (No. 13/2022): contains a series of amendments to Part 3 (ss 47-55) and other procedural changes; those amendments commenced on 30 March 2022 (Endnotes).

Textual markers in the principal Act showing amendment consequences:

• New or modified provisions introduced by later amending Acts are noted inline in the source: for example, s 32 definitions and s 43(7) were amended with insertion references to No. 13/2022 (s 47) and Nos 61/2017, 34/2019, 13/2022 show in‑text inserted subsections (see the brackets and insertion notes in the printed Act).
• The Schedule and several sections (e.g. s 86 standards, s 68 entry powers) carry amendment notes reflecting the legislative history and are cross‑referenced in the Endnotes Table of Amendments.

Practical significance of amendments recorded

• Amendments have added procedural flexibility (e.g. s 58 panel hearing by audio visual link inserted by No. 13/2022, s 58(2)-(4)), clarified entry powers to include audio visual link in s 68(1A) and identification by audiovisual link in s 66(3), and introduced late lodgement windows and fees for renewal in s 43A and s 52A (No. 13/2022). They have also aligned definitions with subsequent Acts (medical cannabis regime, voluntary assisted dying regime) and updated administrative cross‑references (Magistrates’ Court Act, Health Practitioner Regulation National Law).

Recorded commencement history

• The Act was assented on 30 June 2010. The Endnotes identify which sections came into operation on which dates; ss 1-120 and 122-132 commenced on 24 August 2010, with some provisions affected by later proclamations and amendment commencement clauses (Endnotes). Transitional provisions in Part 7 governed the takeover of pharmacy regulatory functions from the old Pharmacy Board of Victoria (ss 111-117).

Limitations of the source

• The Endnotes note that at the date of publication no explanatory details were entered (Endnotes section 3). The Table of Amendments in the source is the only amendment history supplied in this text; any amendments occurring after 30 March 2022 fall outside the source.

The Act’s text and endnotes do not record judicial or tribunal decisions; there are no cases named or summarised in the source document. The Act does, however, establish routes for administrative review and potential litigation, which will generate a litigation record in practice:

• VCAT review: section 62 provides for applications to VCAT by persons affected by certain Authority decisions (refusal to grant licences or registrations, imposition of conditions, revocation). That procedure will be the primary administrative review channel and will produce determinations that the Authority is required to publish on its website (s 62(3)) and notify previously notified persons (s 62(4)). Any published VCAT decisions would form the first part of a litigation history relevant to interpreting the Act in practice.
• Magistrates’ Court jurisdiction: search warrants and seizure matters under s 70 involve magistrates and the Magistrates’ Court Act 1989; prosecutions for offences under the Act will be heard in the Magistrates’ Court or other courts depending on penalty and charge. Section 76 explicitly gives the Magistrates’ Court power to extend retention of seized items.
• Internal procedural constraints likely to generate litigation: the Act clarifies natural‑justice obligations for panel hearings (s 58(1)(e)), sets out limited immunity for Authority members (s 97) and places limits on delegation (s 98). These procedural provisions create potential grounds for dispute about whether the Authority followed correct procedure (e.g. notice requirements in s 40(3), s 49(3) before imposing conditions without consent).

What is missing from the source on litigation

• No decisions, appeal outcomes, or case law developments are recorded in the Act text or the Endnotes. Any authoritative litigation history will come from tribunal and court databases and is not contained in the supplied source. Practitioners needing precedent must therefore search VCAT and court records for matters arising under the Pharmacy Regulation Act 2010 and decisions interpreting its provisions, particularly on points such as the counting of pharmacy businesses for ownership caps (ss 12-19), the scope of “personal supervision” (s 30), and the exercise of entry and seizure powers (ss 67-76).

The Act contains technical rules, exceptions and process traps that commonly catch practitioners who assume straightforward operation.

Ownership and counting rules

• Separate premises counted separately: s 10 treats each pharmacy business carried on at separate premises as a separate pharmacy business even if carried on by the same person or under the same name. This has acquisition and cap consequences (s 5(2); Div 2).
• Subsidiary acquisitions counted if after 16 November 2004: s 18 includes pharmacy businesses owned by a wholly owned subsidiary in the counting for companies referred to in s 5(1)(c) if the subsidiary was acquired or incorporated on or after 16 November 2004. That date‑dependent rule can create retroactivity‑sensitive outcomes when corporate restructures straddle the 2004/2008 thresholds in ss 15-17.
• Rounding up can increase counts: s 19 authorises rounding up the total number of pharmacy businesses to the next whole number when calculating totals under ss 15(b), 16 or 17, which can push an otherwise marginal total over a cap threshold.
• Amalgamation exceptions are date‑sensitive: ss 15-17 carve out complex exceptions for companies formed by amalgamation in particular windows (on/after 16 November 2004 and before 17 November 2008; on/after 17 November 2008). The special rules reference the number of pharmacy businesses owned immediately before certain dates and the largest amalgamating company, producing outcomes that depend on precise historic ownership snapshots.

Contractual pitfalls

• Void provisions in security documents: s 11 voids contractual clauses that confer control over operations, access to books (except for compliance checks) or profit‑linked payments to non‑licensees. Lenders and security holders used to negotiating flexible enforcement mechanisms may find commonly used clauses ineffective or void; this requires re‑drafting security documents to comply with s 11 while still providing enforceable remedies.

Operational ambiguities and timing risks

• “Personally supervised” presence requirement: s 30(1) requires a registered pharmacist to be personally present at all times a pharmacy or department is open for business. The statutory text defines personally supervised as present at the pharmacy or department (s 30(3)). That strict presence test reduces scope for remote supervision models; off‑site managers cannot satisfy s 30(1).
• No right to legal representation at panels but lawyers may accompany: s 58(1)(b) states there is no right to legal representation at panel hearings, while s 58(1)(c) allows the licensee to be accompanied by another person who may be a lawyer. The tension creates procedural nuances , legal counsel may attend but the panel is not obliged to afford the formal protections associated with adversarial legal representation.
• Immediate revocation power: s 60(4) permits revocation of a licence or registration without notice where immediate revocation is necessary to reduce or prevent a serious risk to public health and safety. That creates a sudden‑closure risk for a licensee in crisis scenarios; short notice and limited opportunity to remedy could be operative.
• Entry by audio visual link and ID by audio visual link: s 68(1A) authorises entry to premises physically or by audio visual link, and s 66(3) permits authorised persons to produce identity cards for inspection by audio visual link. These provisions broaden the concept of ‘entry’ and require licensees to prepare systems for remote inspection.
• Self‑incrimination and documents: s 78(2) denies a natural person the right to refuse to produce documents on the ground of self‑incrimination. If a person claims production would incriminate them, s 78(3) bars the document’s admissibility against them in criminal proceedings, but the document may still be used administratively. This partial protection may not meet all legal advisers’ expectations.

Standards and Ministerial oversight

• Standards require Ministerial approval and Gazette publication: s 86(2)-(4) requires consultation with licensees and Ministerial approval before a standard takes effect and mandates publication in the Government Gazette and on the Authority’s Internet site. The requirement for Ministerial approval can slow implementation and creates a point where policy direction can be modified beyond the Authority’s control.
• Emergency standard exception: s 86(7) allows issuance without consultation where immediate public health or safety needs exist. That undermines normal consultation timelines and can result in rapid change to operational expectations.

Administrative and procedural deadlines

• Renewal and late lodgement windows: s 43 requires licence renewals before 1 July annually. Section 43A allows late renewal within 28 days after 30 June with a late lodgement fee fixed by the Authority; the late application preserves licence continuity until the Authority decides (s 43A(3)). Similar late renewal provisions apply to registration in s 52A. Practitioners must be alert to the cut‑off and to fee regimes which the Authority sets and publishes (s 104).
• Notices triggering short cure periods: where the Authority decides to revoke without referring to a panel, s 60(2) allows the Authority to revoke at the end of 28 days or to state an intention to revoke unless satisfactory arrangements are made within a period not less than 28 days. The statutory clock can be material when planning remedial action or preparing for review.

Information disclosure and confidentiality

• Disclosure permitted to certain agencies: s 107 permits the Authority to disclose information to the Pharmacy Board of Australia, to the Secretary in relation to administration of specified Acts, and to corresponding bodies in other jurisdictions. Privacy, confidentiality and cross‑agency data sharing need to be managed with care and understood by licensees.
• Public register: s 63 requires the Authority to maintain a public register including licensees’ names and the number of pharmacies owned. Publication of revocations and conditions is permissible. This creates reputational and commercial consequences for licensees; accuracy and timely correction mechanisms should be prioritized.

Delegation limits and immunity

• Delegation exclusions: s 98 bars delegation of the power to refuse or revoke a licence or registration, Part 4 enforcement powers, and the power of delegation itself. This concentrates critical decisions with the Authority (rather than delegates) and affects internal administrative planning.
• Limited immunity: s 97 provides limited immunity to members acting in good faith under Part 3, but liability attaches to the Authority where immunity would otherwise attach to a member. This changes the risk allocation for members and for the Authority.

A practical compliance checklist grounded in the Act’s obligations follows. Each step maps to statutory provisions so that advisers can identify what must be done and when.

1. Confirm eligibility to own and operate (s 5; s 37)

• Verify whether the intended owner meets one of the permitted classes in s 5(1): individual registered pharmacist, company with all directors and shareholders who are registered pharmacists (s 5(1)(b)), qualifying mutual companies (s 5(1)(c)-(e)), or an Authority‑approved person (s 5(1)(f)).
• For companies, check director and share registers to ensure compliance and prepare documentation to satisfy the Authority under s 5(4) for mutual‑type bodies (evidence that the company is not carrying on business for the dominant purpose of profit, that property and income are applied to objects (s 5(4)(a)-(c))).
• Count existing pharmacy businesses against caps: apply s 5(2) and Division 2 (ss 12-19). Treat separate premises as separate pharmacy businesses (s 10) and apply s 18 and s 19 when subsidiaries were acquired on or after 16 November 2004 or amalgamations occurred in the specified windows (ss 15-17).

2. Notify and document corporate changes (ss 7, 8, 27)

• Lodge any required ASIC filings promptly, and remember to notify the Authority within 30 days when notices are lodged or applications made to ASIC in respect of companies with mutual structure (s 7).
• Be prepared to produce information and documents about ownership to the Authority (s 8). Designate a responsible person to handle Authority requests and ensure timely compliance to avoid s 9 offences.

3. Secure licences and registrations before operating (ss 21-23; 36-45)

• Apply for licence (s 36) and registration of premises (s 44) in writing, providing all information the Authority requires and paying applicable fees (ss 36(2), 44(2)). Consider applying for registration at the same time as the licence (s 44(3)).
• Ensure premises meet the Schedule requirements: layout, hygiene, temperature control, equipment and security (Schedule items 1-4). Prepare evidence of compliance with Schedule items 5-11 on supervision, records, confidentiality and dispensing practices.
• For pharmacy departments in registered funded agencies, expect the Authority to consult the Secretary before registration or licence (s 45(2); s 38(3)).

4. Implement operational procedures (ss 29-33; Schedule)

• Staffing and supervision: roster registered pharmacists to ensure personal supervision at all times the pharmacy is open (s 30(1); Schedule items 5-8). Document backups for temporary absences and names of pharmacists in charge.
• Dispensing and records: establish written or electronic prescription record systems that capture required fields (s 32(3); Schedule items 10-11), certify records with a handwritten signature or alternative certified record within 24 hours (s 32(4)(c)), and retain records securely for at least three years (s 32(4)(a); Schedule 11).
• Depot security and confidentiality: for depots, set up secure storage, confidentiality arrangements and private consultation capability (s 48). Document operator responsibilities and age requirements (s 48(d)).

5. Avoid prohibited contractual terms and prepare security documents (s 11)

• Review and redraft bills of sale, mortgages, leases and other security or finance documents to exclude any clause that would give a non‑licensee the right to control the manner of carrying on the pharmacy business, to access books outside compliance checks, or to receive payments varying according to profits (s 11). Where lenders require recovery mechanisms, use structures compliant with s 11 and seek Authority guidance if necessary.

6. Set up compliance for notices and renewals (ss 20, 25-28, 43, 52)

• Notify the Authority as soon as practicable of intention to establish a pharmacy business (s 20).
• Maintain a calendar for licence and registration renewal before 1 July each year (ss 43(1), 52(1)). If renewal will be late, use the 28‑day late lodgement window with the late lodgement fee fixed by the Authority (ss 43A(1), 52A(1)). Keeping renewal paperwork and fees in order prevents inadvertent lapses of licence or registration.
• Notify the Authority at least 14 days before ceasing to carry on a pharmacy business (s 25) and for changes to company shareholding, directorship or office bearers within 14 days (s 27).
• Ensure registered pharmacists provide required address notifications within 14 days of commencing to supply, compound or dispense medicines at a pharmacy or pharmacy department (s 28).

7. Prepare for inspections and investigations (ss 65-76, 67-68)

• Maintain records and make them readily available for examination; the Authority may require submission of documents (s 67). Ensure staff know to produce identity cards when an authorised person seeks entry and that authorised persons may inspect only while premises are open (s 68(2)).
• Implement a records retention and copying policy that complies with s 74 timelines (copies of seized documents must be provided within 21 days) and s 75 return/retention obligations. If seized items are not returned within three months, plan for possible Magistrates’ Court applications to extend retention (s 76).
• Train staff on how to respond to authorised persons’ requests, including the statutory warning and the effect of s 78, and preserve evidence of any warnings given.

8. Engage with standards and consultative processes (s 86)

• Participate in consultation when the Authority issues standards (s 86(2)), and review standards once published in the Government Gazette (s 86(4)-(6)). Recognise that the Minister must approve standards before they take effect (s 86(3)) and that emergency standards may be issued without consultation (s 86(7)).
• Align internal policies with Authority standards, but in the event of conflict, rely on the Act and regulations which prevail over standards (s 86(8)).

9. Manage risk of sanctions and prepare for panels and VCAT (ss 55-62)

• Establish compliance monitoring to avoid grounds for revocation: eligibility loss, convictions under the Act, contraventions of standards (s 55), security failures, hygiene issues, or failures of good pharmaceutical practice that present serious risk to public health or safety (s 55(b)-(d)).
• If under investigation, collect contemporaneous records, prepare submissions for any panel convened (s 57), and be aware of procedural features: no public hearings by default (s 58(1)(f)), natural justice protections (s 58(1)(e)), and the possibility of appearing by audio visual link (s 58(2)-(4)).
• If aggrieved by an Authority decision, prepare to apply to VCAT within 28 days of receipt of the decision and reasons (s 62(2)). Keep evidence of service and the date the Authority provided reasons to preserve review rights.

10. Financial and administrative housekeeping (ss 102-105, 104)

• Budget for fees and possible fines so the Authority’s fee schedule (s 104) does not cause financial surprise. Ensure fees are paid into the Authority’s processes and maintain records for audit and as required by the Authority for the Fund operations (ss 102-105).
• If the Authority advances funds or receives directions from Ministers regarding repayment (s 105), be prepared to comply or to respond administratively where the Authority requests a plan to repay advances.

11. Data privacy and disclosure control (s 107)

• Be aware of the Authority’s powers